India  

Johnson & Johnson Begins Late-Stage Coronavirus Vaccine Trial

Video Credit: Wochit Business - Duration: 00:32s - Published
Johnson & Johnson Begins Late-Stage Coronavirus Vaccine Trial

Johnson & Johnson Begins Late-Stage Coronavirus Vaccine Trial

Coronavirus deaths have surpassed 206,000 in the U.S as the world awaits a vaccine.

Business Inisder reports that Johnson & Johnson has started a late-stage trial for its coronavirus vaccine.

The 60,000-person trial will be conducted to test the safety and efficacy of the experimental vaccine.

Johnson & Johnson is one of a number of pharmaceutical companies testing vaccines for the deadly virus.

The U.S.


You Might Like

Related news from verified sources

Covid: J&J vaccine shows strong immune response

A single dose of Johnson & Johnson's experimental Covid-19 vaccine produced a strong immune response...
IndiaTimes - Published


Related videos from verified sources

Moderna COVID-19 vaccine appears safe for older adults- study [Video]

Moderna COVID-19 vaccine appears safe for older adults- study

Results from an early safety study of Moderna's coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults,..

Credit: Reuters Studio     Duration: 01:30Published
Johnson & Johnson's Coronavirus Vaccine Enters Phase 3 Trial With Beth Israel [Video]

Johnson & Johnson's Coronavirus Vaccine Enters Phase 3 Trial With Beth Israel

Beth Israel is part of Johnson & Johnsonโ€™s huge study to see if a single-dose coronavirus vaccine will work. WBZ-TV's Bill Shields reports.

Credit: WBZ CBS Boston     Duration: 01:51Published
Johnson & Johnson COVID Vaccine Enters Pivotal Stage [Video]

Johnson & Johnson COVID Vaccine Enters Pivotal Stage

Another COVID vaccine has entered what is described as the pivotal stage before applying for FDA approval. It's a very large phase 3 trial from Johnson and Johnson. CBS2's Dr. Max Gomez says this trial..

Credit: CBS 2 New York     Duration: 02:00Published